Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Bradley Warady to Middle Aged

This is a "connection" page, showing publications Bradley Warady has written about Middle Aged.

 
Connection Strength
  
 
 
0.509
  
  1. Warady BA, Pergola PE, Agarwal R, Andreoli S, Appel GB, Bangalore S, Block GA, Chapman AB, Chin MP, Gibson KL, Goldsberry A, Iijima K, Inker LA, Kashtan CE, Knebelmann B, Mariani LH, Meyer CJ, Nozu K, O'Grady M, Rheault MN, Silva AL, Stenvinkel P, Torra R, Chertow GM. Effects of Bardoxolone Methyl in Alport Syndrome. Clin J Am Soc Nephrol. 2022 12; 17(12):1763-1774.
    View in: PubMed
    Score: 0.194
  2. Rasu RS, Bawa WA, Suminski R, Snella K, Warady B. Health Literacy Impact on National Healthcare Utilization and Expenditure. Int J Health Policy Manag. 2015 Aug 17; 4(11):747-55.
    View in: PubMed
    Score: 0.117
  3. Bryan CF, Winklhofer FT, Murillo D, Ross G, Nelson PW, Shield CF, Warady BA. Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. Transplantation. 2005 Jul 15; 80(1):75-80.
    View in: PubMed
    Score: 0.058
  4. Chertow GM, Appel GB, Andreoli S, Bangalore S, Block GA, Chapman AB, Chin MP, Gibson KL, Goldsberry A, Iijima K, Inker LA, Knebelmann B, Mariani LH, Meyer CJ, Nozu K, O'Grady M, Silva AL, Stenvinkel P, Torra R, Warady BA, Pergola PE. Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome. Am J Nephrol. 2021; 52(3):180-189.
    View in: PubMed
    Score: 0.043
  5. Thumfart J, M?ller D, Wagner S, Jayanti A, Borzych-Duzalka D, Schaefer F, Warady B, Schmitt CP. Barriers for implementation of intensified hemodialysis: survey results from the International Pediatric Dialysis Network. Pediatr Nephrol. 2018 04; 33(4):705-712.
    View in: PubMed
    Score: 0.034
  6. Ng DK, Schwartz GJ, Jacobson LP, Palella FJ, Margolick JB, Warady BA, Furth SL, Mu?oz A. Universal GFR determination based on two time points during plasma iohexol disappearance. Kidney Int. 2011 Aug; 80(4):423-30.
    View in: PubMed
    Score: 0.022
  7. Nelson PW, Shield CF, Muruve NA, Murillo D, Warady BA, Aeder MI, Bryan CF. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system? Am J Transplant. 2002 Jan; 2(1):94-9.
    View in: PubMed
    Score: 0.011
  8. Bryan CF, Luger AM, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS. Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft. Transplantation. 2001 Apr 15; 71(7):875-9.
    View in: PubMed
    Score: 0.011
  9. Bryan CF, Shield CF, Nelson PW, Pierce GE, Ross G, Luger AM, Warady BA, Helling TS, Aeder MI, Martinez J, Hughes TM, Beck ML, Harrell KM. Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys. Transplantation. 1998 Dec 27; 66(12):1714-7.
    View in: PubMed
    Score: 0.009
  10. Bryan CF, Baier KA, Nelson PW, Luger AM, Martinez J, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS, Muruve N. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Transplantation. 1998 Dec 27; 66(12):1827-32.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.